Clincosm LogoSign in Get a demo

Stage IV Melanoma

Showing 76 - 97 of 97
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Recurrent Melanoma, Stage IV Melanoma Trial in Chicago (tipifarnib, laboratory biomarker analysis)

Completed
  • Recurrent Melanoma
  • Stage IV Melanoma
  • Chicago, Illinois
    Cancer and Leukemia Group B
Jun 4, 2013

Recurrent Melanoma, Recurrent Renal Cell Cancer, Stage III Melanoma Trial in New Haven (recombinant interferon alfa-2b,

Completed
  • Recurrent Melanoma
  • +4 more
  • New Haven, Connecticut
    Yale University
May 1, 2013

Recurrent Melanoma, Recurrent Renal Cell Cancer, Stage IV Melanoma Trial in Philadelphia (bryostatin 1, temsirolimus)

Completed
  • Recurrent Melanoma
  • +4 more
  • Philadelphia, Pennsylvania
    Fox Chase Cancer Center
May 1, 2013

Recurrent Melanoma, Stage III Melanoma, Stage IV Melanoma Trial in New York (tanespimycin, laboratory biomarker analysis)

Terminated
  • Recurrent Melanoma
  • +2 more
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
Apr 9, 2013

Male Breast Cancer, Stage IV Breast Cancer, Stage IV Melanoma Trial in Boston (cediranib maleate, whole-brain radiation therapy)

Terminated
  • Male Breast Cancer
  • +9 more
  • cediranib maleate
  • whole-brain radiation therapy
  • Boston, Massachusetts
    Massachusetts General Hospital Cancer Center
Mar 7, 2013

Male Breast Cancer, Recurrent Bladder Cancer, Recurrent Breast Cancer Trial in Los Angeles (decitabine, pharmacological study,

Completed
  • Male Breast Cancer
  • +8 more
  • Los Angeles, California
    University of Southern California
Feb 6, 2013

Stage IIIB Melanoma, Stage IIIC Melanoma, Stage IV Melanoma Trial in Bronx, New York (drug, other, procedure)

Withdrawn
  • Stage IIIB Melanoma
  • +2 more
  • gamma-secretase/Notch signalling pathway inhibitor RO4929097
  • +3 more
  • Bronx, New York
  • +1 more
Jan 30, 2013

Recurrent Melanoma, Stage IV Melanoma Trial in Rochester (tyrosinase peptide, MART-1:27-35 peptide vaccine, gp100 antigen)

Completed
  • Recurrent Melanoma
  • Stage IV Melanoma
  • tyrosinase peptide
  • +5 more
  • Rochester, Minnesota
    Mayo Clinic
Jan 24, 2013

Recurrent Melanoma, Stage IV Melanoma Trial in New York (ixabepilone, pharmacogenomic studies, laboratory biomarker analysis)

Completed
  • Recurrent Melanoma
  • Stage IV Melanoma
  • New York, New York
    New York University Clinical Cancer Center
Jan 24, 2013

Recurrent Melanoma, Stage IV Melanoma Trial in Chicago (semaxanib, laboratory biomarker analysis)

Terminated
  • Recurrent Melanoma
  • Stage IV Melanoma
  • Chicago, Illinois
    University of Chicago Comprehensive Cancer Center
Jan 23, 2013

Recurrent Melanoma, Stage IV Melanoma, Tumors Metastatic to Brain Trial in Chicago (temozolomide, thalidomide)

Completed
  • Recurrent Melanoma
  • +2 more
  • Chicago, Illinois
    Cancer and Leukemia Group B
Jan 15, 2013

Recurrent Melanoma, Stage IV Melanoma Trial in Chicago (aldesleukin, gp100:209-217(210M) peptide vaccine, laboratory biomarker

Completed
  • Recurrent Melanoma
  • Stage IV Melanoma
  • aldesleukin
  • +2 more
  • Chicago, Illinois
    Cancer and Leukemia Group B
Jan 15, 2013

Recurrent Melanoma, Stage IV Melanoma Trial in Rochester (bortezomib, laboratory biomarker analysis)

Completed
  • Recurrent Melanoma
  • Stage IV Melanoma
  • Rochester, Minnesota
    Mayo Clinic
Jan 15, 2013

Stage III Melanoma, Stage IV Melanoma Trial in Bronx (sorafenib tosylate, laboratory biomarker analysis)

Completed
  • Stage III Melanoma
  • Stage IV Melanoma
  • sorafenib tosylate
  • laboratory biomarker analysis
  • Bronx, New York
    Montefiore Medical Center
Jan 14, 2013

Stage III Melanoma, Stage IV Melanoma Trial in Los Angeles, Stuart, Las Vegas (MKC1106-MT)

Terminated
  • Stage III Melanoma
  • Stage IV Melanoma
  • MKC1106-MT
  • Los Angeles, California
  • +3 more
May 10, 2012

Stage IV Melanoma Trial in United States (volociximab)

Terminated
  • Stage IV Melanoma
  • Scottsdale, Arizona
  • +6 more
Apr 25, 2012

Recurrent Melanoma, Stage IV Melanoma Trial in Seattle (drug, biological, other, procedure, genetic)

Completed
  • Recurrent Melanoma
  • Stage IV Melanoma
  • Seattle, Washington
    Fred Hutchinson Cancer Research Center/University of Washington
Mar 14, 2012

Stage IV Melanoma Trial in Seattle (biological, drug, procedure)

Terminated
  • Stage IV Melanoma
  • therapeutic autologous lymphocytes
  • +3 more
  • Seattle, Washington
    Fred Hutchinson Cancer Research Center/University of Washington
Dec 20, 2011

Recurrent Melanoma, Stage III Melanoma, Stage IV Melanoma Trial in Seattle (biological, procedure, other, genetic)

Terminated
  • Recurrent Melanoma
  • +2 more
  • therapeutic autologous lymphocytes
  • +6 more
  • Seattle, Washington
    Fred Hutchinson Cancer Research Center/University of Washington
Dec 2, 2011

Stage IV Melanoma, Stage III Melanoma, Recurrent Melanoma Trial in Rochester, Buffalo, Dallas (allovectin-7)

Completed
  • Stage IV Melanoma
  • +2 more
  • Rochester, Minnesota
  • +2 more
Jul 5, 2011

Malignant Skin Melanoma T0, Stage III Melanoma, Stage IV Melanoma Trial in Paris (Nilotinib)

Unknown status
  • Malignant Skin Melanoma T0
  • +3 more
  • Paris, France
    Hôpital Saint-Louis
Feb 7, 2011

Stage IV Melanoma, Stage III Melanoma, Recurrent Melanoma Trial in United States (allovectin-7, allovectin-7/dacarbazine,

Completed
  • Stage IV Melanoma
  • +2 more
  • Little Rock, Arkansas
  • +43 more
Jul 23, 2008